Posts
May 31 2023
Microbot Medical Inc. announced the closing of its Registered Direct offering in the amount of $2,660,000. EG&S acted as counsel to the Placement Agent.
May 30 2023
Agile Therapeutics, Inc. announced the closing of its Public Offering in the amount of $7,500,000. EG&S acted as counsel to the Placement Agent.
May 30 2023
Client Alert: New York City Enacts Height and Weight Anti-Discrimination Law
Last Friday, May 26, 2023, New York City enacted an anti-discrimination law that prohibits discrimination in employment, housing, and access to public businesses based on an individual’s height or weight. This new law will go into effect on November 22, 2023.
Click here to read the alert.
May 28 2023
Citius Pharmaceuticals, Inc. announced the closing of its Registered Direct offering in the amount of $15,000,000. EG&S acted as counsel to the Placement Agent.
May 25 2023
Acurx Pharmaceuticals, Inc. announced the closing of its Registered Direct offering in the amount of $4,000,000. EG&S acted as counsel to the Placement Agent.
May 23 2023
Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, announced the pricing of its previously announced underwritten public offering. Gross proceeds from the offering are expected to be approximately $4 million. EGS acted as counsel to Maxim Group LLC, the sole book-running manager in the offering.
May 23 2023
NovaBay Pharmaceuticals, Inc. announced the closing of its Private Placement offering in the amount of $3,000,000. EG&S acted as counsel to the Placement Agent.
May 23 2023 Event
Family Leave and Providing Reasonable Accommodation in NYC
Join the Labor & Employment Lawyers from Ellenoff Grossman & Schole LLP for an in-person complimentary breakfast event where we will review Family Leave and Providing Reasonable Accommodations in New York City and earn CLE credits.
Click here to register.